These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 16270527)

  • 21. Cell cycle dysregulation influences survival in high risk breast cancer patients.
    Königsberg R; Rögelsperger O; Jäger W; Thalhammer T; Klimpfinger M; De Santis M; Hudec M; Dittrich C
    Cancer Invest; 2008 Aug; 26(7):734-40. PubMed ID: 18665474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential effects of p21(WAF1/CIP1) deficiency on MMTV-ras and MMTV-myc mammary tumor properties.
    Bearss DJ; Lee RJ; Troyer DA; Pestell RG; Windle JJ
    Cancer Res; 2002 Apr; 62(7):2077-84. PubMed ID: 11929828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prognostic significance of p53, p21 (Waf1/Cip1), and cyclin D1 protein expression in esophageal cancer patients.
    Hirai T; Kuwahara M; Yoshida K; Osaki A; Toge T
    Anticancer Res; 1999; 19(5C):4587-91. PubMed ID: 10650815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic factors in stage T1 grade 3 bladder cancer survival: the role of G1-S modulators (p53, p21Waf1, p27kip1, Cyclin D1, and Cyclin D3) and proliferation index (ki67-MIB1).
    Lopez-Beltran A; Luque RJ; Alvarez-Kindelan J; Quintero A; Merlo F; Carrasco JC; Requena MJ; Montironi R
    Eur Urol; 2004 May; 45(5):606-12. PubMed ID: 15082203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic role of cyclin D1 in non small cell lung cancer: an immunohistochemical analysis.
    Caputi M; De Luca L; Papaccio G; D'Aponte A; Cavallotti I; Scala P; Scarano F; Manna M; Gualdiero L; De Luca B
    Eur J Histochem; 1997; 41(2):133-8. PubMed ID: 9271706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prognostic significance of p53, p27 kip1, p21 waf1, HER-2/neu, and Ki67 proteins expression in gastric cancer: a clinicopathological and immunohistochemical study of 121 Arab patients.
    Al-Moundhri MS; Nirmala V; Al-Hadabi I; Al-Mawaly K; Burney I; Al-Nabhani M; Thomas V; Ganguly SS; Grant C
    J Surg Oncol; 2005 Sep; 91(4):243-52. PubMed ID: 16121348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell cycle proteins in laryngeal cancer: role in proliferation and prognosis.
    Peschos D; Stefanou D; Vougiouklakis T; Assimakopoulos DA; Agnantis NJ
    J Exp Clin Cancer Res; 2005 Sep; 24(3):431-7. PubMed ID: 16270530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Expression and significance of cell cycle regulators in gastric carcinoma].
    Wu JF; Shao JC; Wang DB; Qin R; Zhang H
    Ai Zheng; 2005 Feb; 24(2):175-9. PubMed ID: 15694028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic implications of molecular and immunohistochemical profiles of the Rb and p53 cell cycle regulatory pathways in primary non-small cell lung carcinoma.
    Burke L; Flieder DB; Guinee DG; Brambilla E; Freedman AN; Bennett WP; Jones RT; Borkowski A; Caporaso NA; Fleming M; Trastek V; Pairolero P; Tazelaar H; Midthun D; Jett JR; Liotta LA; Travis WD; Harris CC
    Clin Cancer Res; 2005 Jan; 11(1):232-41. PubMed ID: 15671551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of the cyclin-dependent kinase inhibitor p27Kip1 in gastric cancer.
    Müller W; Grabsch H; Takeno S; Noguchi T; Hommel G; Gabbert HE
    Anticancer Res; 2000; 20(3A):1787-92. PubMed ID: 10928108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression levels of cyclin G2, but not cyclin E, correlate with gastric cancer progression.
    Choi MG; Noh JH; An JY; Hong SK; Park SB; Baik YH; Kim KM; Sohn TS; Kim S
    J Surg Res; 2009 Dec; 157(2):168-74. PubMed ID: 19559447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein levels of p21, p27, cyclin E and Bax predict sensitivity to cisplatin and paclitaxel in head and neck squamous cell carcinomas.
    Taguchi T; Kato Y; Baba Y; Nishimura G; Tanigaki Y; Horiuchi C; Mochimatsu I; Tsukuda M
    Oncol Rep; 2004 Feb; 11(2):421-6. PubMed ID: 14719078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical expression of cell-cycle proteins in gastric precancerous lesions.
    Anagnostopoulos GK; Stefanou D; Arkoumani E; Karagiannis J; Paraskeva K; Chalkley L; Habilomati E; Tsianos E; Agnantis NJ
    J Gastroenterol Hepatol; 2008 Apr; 23(4):626-31. PubMed ID: 18397488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proton pump inhibitors reduce cell cycle abnormalities in Barrett's esophagus.
    Umansky M; Yasui W; Hallak A; Brill S; Shapira I; Halpern Z; Hibshoosh H; Rattan J; Meltzer S; Tahara E; Arber N
    Oncogene; 2001 Nov; 20(55):7987-91. PubMed ID: 11753681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of biomarkers in squamous cell carcinoma of the tongue: multivariate analysis.
    Vora HH; Shah NG; Patel DD; Trivedi TI; Chikhlikar PR
    J Surg Oncol; 2003 Jan; 82(1):34-50. PubMed ID: 12501167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer.
    Mohamed S; Yasufuku K; Hiroshima K; Nakajima T; Yoshida S; Suzuki M; Sekine Y; Shibuya K; Iizasa T; Farouk A; Fujisawa T
    Cancer; 2007 Jun; 109(12):2506-14. PubMed ID: 17487846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cooperative role of p27 with cyclin E in the prognosis of advanced gastric carcinoma.
    Xiangming C; Natsugoe S; Takao S; Hokita S; Tanabe G; Baba M; Kuroshima K; Aikou T
    Cancer; 2000 Sep; 89(6):1214-9. PubMed ID: 11002215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic factors in survival of patients with stage Ta and T1 bladder urothelial tumors: the role of G1-S modulators (p53, p21Waf1, p27Kip1, cyclin D1, and cyclin D3), proliferation index, and clinicopathologic parameters.
    Lopez-Beltran A; Luque RJ; Alvarez-Kindelan J; Quintero A; Merlo F; Requena MJ; Montironi R
    Am J Clin Pathol; 2004 Sep; 122(3):444-52. PubMed ID: 15362377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. P21 (WAF1) expression in colorectal cancer: correlation with P53 and cyclin D1 expression, clinicopathological parameters and prognosis.
    Pasz-Walczak G; Kordek R; Faflik M
    Pathol Res Pract; 2001; 197(10):683-9. PubMed ID: 11700890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of cyclin genes in human gastric cancer and in first degree relatives.
    Yu J; Miehlke S; Ebert MP; Szokodi D; Wehvnignh B; Malfertheiner P; Ehninger G; Bayerdoerffer E
    Chin Med J (Engl); 2002 May; 115(5):710-5. PubMed ID: 12133540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.